{"id":481342,"title":"Notice of amendment: Addition of melatonin to the Prescription Drug List - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T16:26:18.868000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/addition-melatonin.html?wbdisable=true","snippet":"Notice of amendment: Addition of melatonin to the Prescription Drug List September 9, 2025 Our file number: 25-105825-747 The purpose of this Notice of Amendment is to announce the addition of \"melatonin or its salts\" to the human use part of the Prescription Drug List (PDL).…","rawSnapshotUrl":"/api/snapshots/raw/481342","browseUrl":"https://replay.healtharchive.ca/job-6/20260106162618/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/addition-melatonin.html?wbdisable=true#ha_snapshot=481342","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}